These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 7973479)
1. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Wolfe F; Cathey MA; Hawley DJ Scand J Rheumatol; 1994; 23(5):255-9. PubMed ID: 7973479 [TBL] [Abstract][Full Text] [Related]
2. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up. Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027 [TBL] [Abstract][Full Text] [Related]
3. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467 [TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Holman AJ; Myers RR Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Distler O; Eich W; Dokoupilova E; Dvorak Z; Fleck M; Gaubitz M; Hechler M; Jansen JP; Krause A; Bendszus M; Pache L; Reiter R; Müller-Ladner U Arthritis Rheum; 2010 Jan; 62(1):291-300. PubMed ID: 20039417 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder. Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936 [TBL] [Abstract][Full Text] [Related]
11. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668 [TBL] [Abstract][Full Text] [Related]
12. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial. Gür A; Karakoc M; Nas K; Cevik R; Sarac J; Ataoglu S Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864 [TBL] [Abstract][Full Text] [Related]
13. Effects of unilateral repetitive transcranial magnetic stimulation of the motor cortex on chronic widespread pain in fibromyalgia. Passard A; Attal N; Benadhira R; Brasseur L; Saba G; Sichere P; Perrot S; Januel D; Bouhassira D Brain; 2007 Oct; 130(Pt 10):2661-70. PubMed ID: 17872930 [TBL] [Abstract][Full Text] [Related]
14. History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release. Pae CU; Masand PS; Marks DM; Krulewicz S; Han C; Peindl K; Mannelli P; Patkar AA World J Biol Psychiatry; 2009; 10(4 Pt 2):435-41. PubMed ID: 19382010 [TBL] [Abstract][Full Text] [Related]
15. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Russell IJ; Perkins AT; Michalek JE; Arthritis Rheum; 2009 Jan; 60(1):299-309. PubMed ID: 19116896 [TBL] [Abstract][Full Text] [Related]
16. Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran. Arnold LM; Palmer RH; Gendreau RM; Chen W Psychosomatics; 2012; 53(4):371-9. PubMed ID: 22677218 [TBL] [Abstract][Full Text] [Related]
17. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036 [TBL] [Abstract][Full Text] [Related]
18. A randomized double-blind clinical trial on analgesic efficacy of fluoxetine for persistent somatoform pain disorder. Luo YL; Zhang MY; Wu WY; Li CB; Lu Z; Li QW Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1522-5. PubMed ID: 19733606 [TBL] [Abstract][Full Text] [Related]